Europe Influenza Vaccine Market (2025-2031) | Companies, Outlook, Size, Revenue, Forecast, Analysis, Growth, Share, Value, Trends & Industry

Name: Europe Influenza Vaccine Market | Size, Share & Volume 2031
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy
Keywords: Influenza Vaccine Market, Europe Influenza Vaccine Market, Europe Influenza Vaccine Market Revenues, Europe Influenza Vaccine Market Share, Europe Influenza Vaccine Market Size, Europe Influenza Vaccine Market Outlook, Europe Influenza Vaccine Market Report, Europe Influenza Vaccine Market Competition, Europe Influenza Vaccine Market Overview, Europe Influenza Vaccine Market Trends, Europe Influenza Vaccine Market Forecast

Market Forecast by Countries (Germany, United Kingdom, France, Italy, Russia, Spain, Rest of Europe), By Vaccine type (Quadrivalent, Trivalent), By Type (Seasonal, Pandemic), By Technology (Egg-based, Cell-based), By Age Group (Pediatric, Adult), By Route of Administration (Injection, Nasal Spray) And Competitive Landscape

Product Code: ETC078971	Publication Date: Aug 2021	Updated Date: Oct 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Ravi Bhandari	No. of Pages: 200	No. of Figures: 90	No. of Tables: 30

Europe Influenza Vaccine Market Size & Growth Rate

According to 6Wresearch internal database and industry insights, the Europe Influenza Vaccine Market was accounted at USD 1.25 billion in 2024 and is projected to reach nearly USD 3.01 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.4% during the forecast period (2025-2031).

Europe Influenza Vaccine Market Highlights

Report Name	Europe Influenza Vaccine Market
Forecast period	2025-2031
CAGR	6.4%
Market Size	USD 3.01 billion by 2031
Growing Sector	Healthcare & Pharmaceutical

Topics Covered in the Europe Influenza Vaccine Market Report

Europe Influenza Vaccine Market report thoroughly covers the market by vaccine type, technology, age group, route of administration, and countries. The market report provides an unbiased and detailed analysis of ongoing market trends, opportunities/high growth areas, and market drivers, which would help stakeholders to devise and align their market strategies according to the current and future market dynamics.

Europe Influenza Vaccine Market Synopsis

Europe Influenza Vaccine Market is expected to grow vigorously in the upcoming years, due to more people getting cognizant of seasonal flu and government conducting vaccination programs. Nations are spending more on healthcare sector. Growing focus among countries across Europe to protect children, adults, and seniors through wider vaccinations. Additionally, advancements in technology are making vaccines safer and more effective encouraging higher adoption by healthcare providers backed by government programs for prevention and disease management.

Evaluation of Growth Drivers in the Europe Influenza Vaccine Market

Below are some prominent drivers and their influence on market dynamics:

Drivers	Primary Segments Affected	Why It Matters (Evidence)
Government Immunization Programs	All vaccine types	Germany and UK vaccination programs boost flu vaccine adoption among high-risk groups.
Increasing Seasonal Flu Incidence	Adult, Pediatric Age Groups	Seasonal influenza outbreaks drive hospitals and clinics to conduct regular vaccination drives.
Technological Advancements	Egg-based, Cell-based	New vaccine tech: Cell-based and recombinant enhance vaccine safety, effectiveness, and production speed.
Awareness & Education Campaigns	Adult, Pediatric Age Groups	Awareness and education campaigns encourage more people to get vaccinated across Europe.
Rising Healthcare Expenditure	All vaccine types	Higher healthcare spending supports broader vaccine access and immunization programs.

The Europe Influenza Vaccine Market is projected to grow at a CAGR of 6.4% during the forecast period of 2025-2031. The market is driven by several key factors which include increased awareness among all kind of age groups about seasonal flu and the need for preventive measures such as on-time vaccination. Governments through initiatives and programs are constantly urging people for vaccination. Improved accessibility achieved through higher spending on healthcare sector covering wide range of hospitals, clinics, and community health centers is further boosting growth. Advances in vaccine technology; the cell-based and recombinant methods due to their higher safety and effectiveness features are getting popular and encouraging wider use of adoption among healthcare providers.

Evaluation of Restraints in the Europe Influenza Vaccine Market

Below are some major restraints and their influence on market dynamics:

Restraints	Primary Segments Affected	What This Means (Evidence)
High Vaccine Costs	Quadrivalent, Trivalent	High vaccine costs limit use in low-income areas.
Vaccine Hesitancy	Pediatric, Adult Age Groups	Misinformation and safety fears reduce vaccine acceptance.
Cold Chain & Storage Requirements	All types	Cold chain needs to raise costs and hinder distribution.
Supply Chain Disruptions	All vaccine types	Supply delays affect vaccine availability in flu season.
Regulatory Challenges	All vaccine types	Strict EU regulations slow product approvals and launches.

Europe Influenza Vaccine Market Challenges

There are significant hurdles faced by the Europe Influenza Vaccine Industry. Expensive vaccines, supply chain problems and stringent regulations can slow down on-time distribution. Some people may be hesitant to get vaccinated due to lack of education and awareness. Poor cold storage facilities obstruct the reach to rural regions. Companies must ensure steady supply while complying with regulations, along with promoting vaccination benefits through programs to support market growth.

Europe Influenza Vaccine Market Trends

There are several notable trends shaping the market dynamics:

Shift to Quadrivalent Vaccines: Increasing Demand for quadrivalent vaccines as they offer broader protection against four flu strains.
Cell-based and Recombinant Technologies: Modern production methods improve vaccine strength, cut mutation risks, and speed up supply.
Focus on High-risk Age Groups: Expanded vaccination drives for children, adults, and seniors are boosting coverage and reducing flu-related hospitalizations.
Combination Vaccines: Dual-purpose vaccines, such as flu + COVID-19 or flu + pneumococcal, are improving convenience and uptake.
Public Awareness Programs: Health campaigns and educational efforts are increasing public trust and participation in vaccination.

Investment Opportunities in the Europe Influenza Vaccine Market

Potential investment opportunities in the Europe Influenza Vaccine Market include:

Quadrivalent Vaccine Expansion: Increasing production to supply vaccines that offer wider flu protection.
Advanced Technologies: Using cell-based and recombinant methods to make vaccines stronger and faster to produce.
Cold Chain Systems: Improving storage and transport to deliver vaccines safely across Europe.
Health Awareness Programs: Supporting education and government efforts to raise vaccination rates.
Combination Vaccines: Creating multi-use vaccines for better coverage and easier patient use.

Top 5 Leading Players in the Europe Influenza Vaccine Market

Some leading players dominating the Europe Influenza Vaccine Market Share include:

1. GlaxoSmithKline (GSK)

Company Name	GlaxoSmithKline (GSK)
Establishment Year	2000
Headquarter	Brentford, United Kingdom
Official Website	Click here

Global leader in influenza vaccines offering a wide range of quadrivalent and seasonal vaccines, focusing on innovation, high efficacy, and wide European distribution.

2. Sanofi Pasteur

Company Name	Sanofi Pasteur
Establishment Year	2004
Headquarter	Lyon, France
Official Website	Click here

Specializes in trivalent and quadrivalent influenza vaccines, leveraging advanced egg-based and recombinant technologies, and strong government partnerships across Europe.

3. Seqirus

Company Name	Seqirus
Establishment Year	2015
Headquarter	Maidenhead, United Kingdom
Official Website	Click here

Key player in cell-based and recombinant influenza vaccines, providing seasonal flu vaccines for adult and pediatric populations across Europe.

4. Abbott Laboratories

Company Name	Abbott Laboratories
Establishment Year	1888
Headquarter	Abbott Park, Illinois, United States
Official Website	Click here

Offers influenza vaccines and diagnostic solutions, focusing on innovative technologies and preventive healthcare solutions in Europe.

5. Bavarian Nordic

Company Name	Bavarian Nordic
Establishment Year	1994
Headquarter	Kvistgaard, Denmark
Official Website	Click here

Provides influenza vaccines including pandemic and seasonal options, emphasizing cell-based technologies and rapid production capabilities.

Government Regulations Introduced in the Europe Influenza Vaccine Market

Governments across Europe have implemented policies to support influenza vaccination and preventive healthcare. Examples include Germany’s National Immunization Plan: Promotes nationwide flu shots through funding and public awareness. UK NHS Seasonal Flu Program: Provides free yearly flu vaccines to priority groups. France’s Vaccination Strategy for High-Risk Groups: Offers low-cost flu shots for high-risk people. Italy’s National Vaccine Prevention Plan: Expands flu vaccine access nationwide. European Commission Recommendations on Seasonal Influenza Vaccination Coverage: Urges countries to vaccinate most high-risk people.

Future Insights of the Europe Influenza Vaccine Market

The future of the Europe Influenza Vaccine Market Growth looks optimistic due to increasing awareness about flu prevention supported by government initiatives that are working on increasing the reach of vaccination in all areas. Technological advancements especially the focus on quadrivalent and cell-based vaccines will drive strong market growth in the upcoming years. Awareness programs are reminding people to get vaccinated each year. Henceforth, this governments and manufacturers partnership will propel Europe’s vaccine supply.

Market Segmentation Analysis

The report offers a comprehensive study of the subsequent market segments and their leading categories.

Quadrivalent to Dominate the Market - by Vaccine Type

According to Priya, Senior Research Analyst, 6Wresearch, Quadrivalent vaccines, which protect against two influenza A strains and two influenza B strains, are expected to dominate due to broader coverage and higher adoption by national immunization programs.

Seasonal Influenza Vaccines to Lead the Market - by Type

Seasonal vaccines hold the largest market share, supported by annual vaccination campaigns for pediatric, adult, and elderly populations. Growing awareness of yearly flu risks and strong government procurement programs drive their widespread adoption.

Egg-based Vaccines to Dominate the Market - by Technology

Egg-based vaccines remain the most widely used due to established production methods, regulatory approval, and cost-effectiveness, though cell-based vaccines are growing in adoption.

Adult Segment to Lead by Age Group

The adult population, particularly high-risk adults over 50, dominates vaccine uptake, driven by public health initiatives and government vaccination programs. Increasing workplace immunization drives and awareness campaigns further strengthen vaccination.

Injection to Dominate by Route of Administration

Injectable vaccines lead the market due to their efficacy, regulatory approval, and wide acceptance among healthcare providers. Ongoing improvements in injection delivery systems and wider availability support their continued dominance.

Germany to Dominate the Europe Market by Countries

Germany is projected to hold the largest market share owing to strong immunization programs, high healthcare expenditure, and large adult and elderly populations targeted for vaccination.

Key Attractiveness of the Report

10 Years Market Numbers
Historical Data Starting from 2021 to 2024
Base Year: 2024
Forecast Data until 2031
Key Performance Indicators Impacting the Market
Major Upcoming Developments and Projects

Key Highlights of the Report:

Europe Influenza Vaccine Market Outlook
Market Size of Europe Influenza Vaccine Market, 2024
Forecast of Europe Influenza Vaccine Market, 2031
Historical Data and Forecast of Europe Influenza Vaccine Revenues & Volume for the Period 2021 - 2031
Europe Influenza Vaccine Market Trend Evolution
Europe Influenza Vaccine Market Drivers and Challenges
Europe Influenza Vaccine Price Trends
Europe Influenza Vaccine Porter's Five Forces
Europe Influenza Vaccine Industry Life Cycle
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Vaccine type for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Quadrivalent for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Trivalent for the Period 2021 - 2031
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Type for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Seasonal for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Pandemic for the Period 2021 - 2031
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Technology for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Egg-based for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Cell-based for the Period 2021 - 2031
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Age Group for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Pediatric for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Adult for the Period 2021 - 2031
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
Historical Data and Forecast of Europe Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
Historical Data and Forecast of Germany Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
Historical Data and Forecast of United Kingdom Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
Historical Data and Forecast of France Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
Historical Data and Forecast of Italy Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
Historical Data and Forecast of Russia Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
Historical Data and Forecast of Spain Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Injection for the Period 2021 - 2031
Historical Data and Forecast of Rest of Europe Influenza Vaccine Market Revenues & Volume By Nasal Spray for the Period 2021 - 2031
Europe Influenza Vaccine Market - Key Performance Indicators
Europe Influenza Vaccine Market - Import Export Trade Statistics
Europe Influenza Vaccine Market - Opportunity Assessment By Countries
Europe Influenza Vaccine Market - Opportunity Assessment By Vaccine type
Europe Influenza Vaccine Market - Opportunity Assessment By Type
Europe Influenza Vaccine Market - Opportunity Assessment By Technology
Europe Influenza Vaccine Market - Opportunity Assessment By Age Group
Europe Influenza Vaccine Market - Opportunity Assessment By Route of Administration
Europe Influenza Vaccine Market - Top Companies Market Share
Europe Influenza Vaccine Market - Top Companies Profiles
Europe Influenza Vaccine Market - Comparison of Players in Technical and Operating Parameters
Europe Influenza Vaccine Market - Strategic Recommendations

Market Scope and Segmentation

The report provides a detailed analysis of the following market segments:

By Vaccine Type

Quadrivalent
Trivalent

By Type

Seasonal
Pandemic

By Technology

Egg-based
Cell-based

By Age Group

Pediatric
Adult

By Route of Administration

Injection
Nasal Spray

By Countries

Germany
United Kingdom
France
Italy
Russia
Spain
Rest of Europe

Europe Influenza Vaccine Market (2025-2031): FAQs

What is the growth outlook for the Europe Influenza Vaccine Market?

What is the Europe Influenza Vaccine Market size?

Which age group has the largest share in the Europe Influenza Vaccine Market?

Which country dominates the Europe Influenza Vaccine Market?

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Europe Influenza Vaccine Market Overview

3.1 Europe Regional Macro Economic Indicators

3.2 Europe Influenza Vaccine Market Revenues & Volume, 2021 & 2031F

3.3 Europe Influenza Vaccine Market - Industry Life Cycle

3.4 Europe Influenza Vaccine Market - Porter's Five Forces

3.5 Europe Influenza Vaccine Market Revenues & Volume Share, By Countries, 2021 & 2031F

3.6 Europe Influenza Vaccine Market Revenues & Volume Share, By Vaccine type, 2021 & 2031F

3.7 Europe Influenza Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F

3.8 Europe Influenza Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.9 Europe Influenza Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F

3.10 Europe Influenza Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

4 Europe Influenza Vaccine Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Europe Influenza Vaccine Market Trends

6 Europe Influenza Vaccine Market, 2021 - 2031

6.1 Europe Influenza Vaccine Market, Revenues & Volume, By Vaccine type, 2021 - 2031

6.2 Europe Influenza Vaccine Market, Revenues & Volume, By Type, 2021 - 2031

6.3 Europe Influenza Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031

6.4 Europe Influenza Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031

6.5 Europe Influenza Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031

7 Germany Influenza Vaccine Market, 2021 - 2031

7.1 Germany Influenza Vaccine Market, Revenues & Volume, By Vaccine type, 2021 - 2031

7.2 Germany Influenza Vaccine Market, Revenues & Volume, By Type, 2021 - 2031

7.3 Germany Influenza Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031

7.4 Germany Influenza Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031

7.5 Germany Influenza Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031

8 United Kingdom Influenza Vaccine Market, 2021 - 2031

8.1 United Kingdom Influenza Vaccine Market, Revenues & Volume, By Vaccine type, 2021 - 2031

8.2 United Kingdom Influenza Vaccine Market, Revenues & Volume, By Type, 2021 - 2031

8.3 United Kingdom Influenza Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031

8.4 United Kingdom Influenza Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031

8.5 United Kingdom Influenza Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031

9 France Influenza Vaccine Market, 2021 - 2031

9.1 France Influenza Vaccine Market, Revenues & Volume, By Vaccine type, 2021 - 2031

9.2 France Influenza Vaccine Market, Revenues & Volume, By Type, 2021 - 2031

9.3 France Influenza Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031

9.4 France Influenza Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031

9.5 France Influenza Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031

10 Italy Influenza Vaccine Market, 2021 - 2031

10.1 Italy Influenza Vaccine Market, Revenues & Volume, By Vaccine type, 2021 - 2031

10.2 Italy Influenza Vaccine Market, Revenues & Volume, By Type, 2021 - 2031

10.3 Italy Influenza Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031

10.4 Italy Influenza Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031

10.5 Italy Influenza Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031

11 Russia Influenza Vaccine Market, 2021 - 2031

11.1 Russia Influenza Vaccine Market, Revenues & Volume, By Vaccine type, 2021 - 2031

11.2 Russia Influenza Vaccine Market, Revenues & Volume, By Type, 2021 - 2031

11.3 Russia Influenza Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031

11.4 Russia Influenza Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031

11.5 Russia Influenza Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031

12 Spain Influenza Vaccine Market, 2021 - 2031

12.1 Spain Influenza Vaccine Market, Revenues & Volume, By Vaccine type, 2021 - 2031

12.2 Spain Influenza Vaccine Market, Revenues & Volume, By Type, 2021 - 2031

12.3 Spain Influenza Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031

12.4 Spain Influenza Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031

12.5 Spain Influenza Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031

13 Rest of Europe Influenza Vaccine Market, 2021 - 2031

13.1 Rest of Europe Influenza Vaccine Market, Revenues & Volume, By Vaccine type, 2021 - 2031

13.2 Rest of Europe Influenza Vaccine Market, Revenues & Volume, By Type, 2021 - 2031

13.3 Rest of Europe Influenza Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031

13.4 Rest of Europe Influenza Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031

13.5 Rest of Europe Influenza Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031

14 Europe Influenza Vaccine Market Key Performance Indicators

15 Europe Influenza Vaccine Market - Opportunity Assessment

15.1 Europe Influenza Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F

15.2 Europe Influenza Vaccine Market Opportunity Assessment, By Vaccine type, 2021 & 2031F

15.3 Europe Influenza Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F

15.4 Europe Influenza Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F

15.5 Europe Influenza Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F

15.6 Europe Influenza Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

16 Europe Influenza Vaccine Market - Competitive Landscape

16.1 Europe Influenza Vaccine Market Revenue Share, By Companies, 2021

16.2 Europe Influenza Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters

17 Company Profiles

18 Recommendations

19 Disclaimer

Africa Influenza Vaccine Market

Asia Influenza Vaccine Market

Asia Pacific Influenza Vaccine Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here